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ABSTRACT 
OBJECTIVE: To create a care pathway for patients with a newly detected brain tumor, by 
examining common diagnostic pathways for patients diagnosed with a primary brain tumor or a 
central nervous system metastasis. 
MATERIALS AND METHODS: All patients diagnosed atMGH between 1?1?95 and 
12/31/97 with a primary brain tumor or a central nervous system metastasis were studied. Only 
patients who displayed one or two brain lesions and presented to the MGH emergency ward or 
transferred in from another emergency ward were included in the study. Clinical characteristics, 
use and results of radiological testing, and final diagnostic procedures were evaluated. 
RESULTS: Forty-eight patients were selected for the study. The most common ancillary test 
performed was a chest x-ray; 97.9% ofthe patients received a chest x-ray, while only 18.8% 
received a chest CT. None of the chest CT examinations showed a diagnostically significant 
different from the chest x-ray. Other ancillary scanning was done infrequently. 
DISCUSSION: A relatively small proportion of patients with a newly detected brain lesion 
received any type of ancillary testing beyond a chest x-ray. A chest x-ray appeared to change the 
biopsy site from the brain to another site in about 50% of the cases. Not enough chest CT 
examinations were done to determine their effectiveness. However, the resuhs seem to indicate 
that the preliminary diagnosis of the admitting physician is not necessarily based upon the results 
of a chest x-ray or other ancillary testing. 
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INTRODUCTION 
Brain tumors have been diagnosed in about 34,000 people annually in the United States 
(7). Brain tumors can be classified into two groups, depending upon where the tumor originated 
in the body. Primary brain tumors originate in the brain, while metastatic brain tumors are formed 
from cancer cells which travel to the brain from a distant site in the body (3). Although the annual 
deaths from metastatic brain tumors has been estimated to be at least 2 1/2 times greater than those 
from primary brain tumors ( 4), both primary and metastatic brain tumors are diagnosed about in 
equal numbers annually (7). Primary and metastatic tumors can be further classified according to 
their cellular component. This histological diagnosis is necessary before treatment ofthe tumor 
can begin, since the treatments for brain tumors vary depending upon the particular tumor type 
(1,3,6). 
There are a variety of diagnostic methods available to detect these tumors. Clinically, 
brain tumors display both neurological symptoms, such as seizure, sensory changes, and altered 
mental status, and systemic symptoms (1,2). Since these symptoms are shared with many other 
brain abnormalities, radiological imaging is used to distinguish between them (1). Computed 
tomography scans (CT) and a magnetic resonance imaging (MRI) are the most common devices 
used for detection of structural brain abnormalities, and can often distinguish between brain 
tumors, other brain lesions, and occasionally between tumor types (1,5). Less commonly used 
diagnostic tests include magnetic resonance angiography, electroencephalography (EEG), and 
cerebral spinal fluid analysis (CSF) (1). In patients with a brain lesion, histological diagnosis from 
a biopsy is usually needed to confirm the tumor and its classification, as well as to determine the 
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treatment regimen. 
Once a brain lesion has been detected in a patient not previously known to have cancer, 
the initial diagnostic procedures vary greatly. Depending on the nature of the brain lesion, the 
neurosurgeon may elect to completely remove, or resect, the lesion (6). Alternatively, a biopsy is 
done when small tissue sample can be removed. Particularly in patients where only a biopsy is 
indicated, finding a biopsy site other than the brain is often preferable. Thus, some patients may 
receive ancillary testing to determine if metastatic cancer is present at distant sites in the body. 
Radiological testing may include a chest x-ray, a chest CT, an abdominal CT, and a 
radionucleotide bone scan. Since there is no basic pathway by which most of these patients are 
evaluated, it is not known how often ancillary testing is done, or how useful it is in guiding further 
diagnosis and treatment of the patient. It is also unknown how often an abnormal result on a 
particular ancillary test will change the biopsy site from the brain to another organ, i.e. the lung. 
Because radiologic and laboratory procedures are very costly, it is desirable to know what 
imaging is necessary to bring about a decision for definitive diagnosis and treatment of a 
suspected brain tumor. This initial treatment process alone has been shown to require an estimated 
75% of the total cost of treatment of high-grade astrocytomas, a common primary brain cancer 
(6). By eliminating unnecessary diagnostic testing, the money and time spend to diagnose a newly 
detected brain mass could be significantly reduced, which would help reduce the overall costs of 
treating brain tumors. To facilitate this, care pathways or algorithms are often created to 
determine the best method of diagnosing or treating a patient, with the least amount of wasted 
resources. 
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The purpose of this preliminary study is to attempt to create a care pathway for patients 
with a newly detected brain mass, by examining common diagnostic pathways from the case 
histories of such patients seen at the Massachusetts General Hospital (MGH) between 1995-1997. 
More specifically, this study will attempt to examine how often a chest CT changes the biopsy 
site away from the brain, as opposed to a chest x-ray, in patients displaying one or two brain 
lesions. Patient cases will be retrospectively reviewed to identify all diagnostic testing done and 
their final diagnostic procedure. 
MATERIALS AND METHODS 
Patient Selection 
Patients diagnosed at MGH with first-time primary brain tumor or central nervous system 
(CNS) metastasis between January 1, 1995 to December 31, 1997 were obtained from the Cancer 
Data Registry at MGH. The cases were retrospectively examined to select patients who either 
presented directly, or transferred in to the MGH emergency ward (EW) at the time of their brain 
lesion detection, and had only one or two brain lesions. The following factors were used as 
patient exclusion criteria: (1) patients who already had diagnosed cancer; (2) patients who did not 
have an intracranial brain lesion; (3) patients who had a previous histological diagnosis done 
previous to admission to MGH; (4) patients with three or more brain lesions; (5) patients who did 
not admit to MGH EW or transfer in from another EW; and (6) patients diagnosed with acquired 
immune deficiency syndrome. 
Data Collection 
For each of the patients, clinical and diagnostic data were abstracted: date ofbirth, gender, 
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date of symptom onset, neurological and systemic symptoms, results of the EW physical exam. 
Neurological symptoms included altered mental status, language, vision or sensory changes, 
weakness or paralysis, clumsiness, and gait changes. Systemic symptoms included weight loss, 
abnormal cough, pain, vaginal bleeding, nausea/vomiting, fever, and fatigue. The date and result 
of all initial diagnostic testing was recorded, including the :first CT and MRI scan, chest x-ray, 
chest CT, abdomen/pelvic CT, RN bone scan, including the final diagnostic procedure, site and 
results. The radiographic test results were reported as abnormal when the image indicated 
possible cancerous nodules or lesions, or an air-space disease, such as pneumonia. 
RESULTS 
A total of 442 patients were diagnosed with a primary brain tumor or CNS metastasis at 
MGH :from January 1, 1995 to December 31,1997. Two hundred ninety-five were diagnosed 
with primary brain tumors, while 147 were diagnosed with CNS metastases. To date, 349 files 
have been reviewed: all 14 7 metastatic brain tumors files and 202 primary brain tumor files. Of 
these, a total of 48 (13.8%) patients fit the study selection criteria. Thirty-eight patients (72.9%) 
were ultimately diagnosed with a primary brain tumor, and 10 (20.8%) were diagnosed with a 
metastatic brain tumor. 
Of the 48 selected patients, the mean age of the patients was 53 and median age was 60 
(range 5-90 years). Thirty-three (68.8%) were male, fifteen (31.3%) were female. The most 
commonly presented symptoms were neurological in nature; only one patient did not present with 
neurological symptoms. However, the majority of the patients (75.0%) did not present with 
systemic symptoms. Table 1 indicates the frequency of ancillary testing done. A chest x-ray was 
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done the most frequently, while only nine patients received a chest CT (Table 1). Abdominal 
CTs were done even less frequently, and no patients had radionucleotide bone scanning done 
(Table 1). 
Table 2 shows the distribution of ancillary scanning and final diagnosis among the 47 
patients receiving a chest x-ray. Thirty-five (74.5%) ofthe chest x-rays revealed normal chest 
examinations, while 12 (25.5%) showed possible lung masses or air-space diseases. Nine patients 
also received a chest CT; seven ofthese exams were for further characterization of an abnormal 
chest x-ray (Table 2). Only two patients with a normal chest x-ray received a chest CT and both 
resulted in a normal chest examination (Table 2). Five patients received an abdominal CT of 
which these were positive for an abnormality and all three also had normal chest x-ray 
examinations (Table 2). All patients who had a normal chest x-ray had a brain procedure, or 
craniotomy, done for diagnosis (Table 2). However, the diagnosis site for those who had 
abnormal chest x-rays showed greater variation (Table 2). Of the 35 patients who had a normal 
chest x-ray, only four had metastatic cancer. Of the 12 patients with abnormal chest x-rays, half 
had metastatic cancer. 
Table 3 compares the results of patients who received both a chest x-ray and a chest CT 
examination. All of the patients who had metastatic cancer had an abnormal chest x-ray and chest 
CT, while only one patient who had a primary brain tumor had an abnormal chest x-ray and chest 
CT (Table 3). Out ofa119 patients who received both a chest x-ray and a chest CT, none ofthem 
had conflicting test results (Table 3). 
Table 4 shows the diagnostic history of four patients who had a normal chest x-ray had 
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metastatic cancer. The specific ancillary testing and diagnostic test for each of these patients is 
listed in Table 4. None of these patients received any further ancillary testing. Three out ofthe 
four had a brain resection, while only one received a brain biopsy. Table 5 shows the type of 
diagnostic testing done for patients who had an abnormal chest x-ray. All patients whose final 
diagnosis was a primary brain tumor had their first diagnostic procedure done in the brain 
(excluding one patient who did not have any further diagnostic testing for their brain lesion except 
a head scan). Likewise all patients whose final diagnosis was metastatic cancer had their first 
diagnostic procedure perform at a location other than the brain (excluding one patient who did 
not have any further diagnostic testing). 
Table 6 shows the differences in ancillary testing and diagnosis based on the number of 
lesions each patient had. Forty patients (83.3%) had a single brain lesion, while 8 (16.7%) had 
two brain lesions. Six people from each category had an abnormal chest x-ray. This shows a 
much higher percentage of abnormal chest x-rays for patients with two brain lesions (75.0%) as 
compared to patients with only one lesion (15.0%). There is a much higher percentage of 
diagnostic procedures done in the brain for patients with only one brain lesion (95.0%), than for 
patients with two brain lesions (3 7.5% ). Half of the patients with two brain lesions had a 
diagnostic test done outside of the brain, while only one patient with one brain lesion had a 
diagnostic test done outside of the brain. The majority of patients with only one brain lesion had a 
primary brain tumor, while the majority of patients with two brain lesions had metastatic cancer. 
DISCUSSION 
From the data collected so far, over seventy-five percent, it appears that a relatively small 
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proportion of patients with a newly detected brain lesion received any type of ancillary testing 
further than a chest x-ray. A normal chest x-ray was more common for patients with primary 
brain tumors; however an equal number of patients with primary brain tumors and metastatic brain 
tumors had abnormal chest x-rays (Table 2). Of these, two patients required brain resection. 
Thus, five out often patients with an abnormal chest x-ray, who were eligible for a brain biopsy, 
had a biopsy done at a non-brain site. So in 50% of patients with an abnormal chest x-ray, the 
biopsy site moved away from the brain. 
The other ancillary scanning was not done enough to determine any significant trends. 
Only nine patients received both a chest x-ray and chest CT, and none of the chest CT 
examinations showed a diagnostically significant difference (Table 3). Seven patients with 
abnormal chest x-rays also had a chest CT done to characterize the x-ray results further. Of the 
seven patients who had abnormal chest CT results, five (71.4%) had a diagnostic procedure done 
at a non-brain site (Table 2). This percentage is misleading though, because so few patients 
received both chest x-ray and chest CT examinations. It is possible that though the additional 
information provided by the chest CT influenced the selection of a non-brain biopsy site more than 
the chest x-ray did. However, the relative value of a chest x-ray versus a chest CT can not be 
compared from this data, because not all patients received both a chest x-ray and CT exam. 
Three patients who had an abnormal chest x-rays, and did not require brain resection, did not have 
a chest CT done, so it is not known how this test might have influenced the selection of a biopsy 
site. 
Interestingly, the results seem to indicate that the preliminary diagnosis of the admitting 
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physician is not necessarily based upon the results of a chest x-ray or other ancillary testing. The 
data indicate that only four patients who had a normal chest x-ray had a craniotomy procedure 
whose resulting diagnosis was metastatic cancer (Table 2). Three of these were a resection 
procedure, rather than a biopsy procedure (Table 4). Thus only one patient had received a 
craniotomy when a less invasive procedure might have been able to be done. None of the patients 
who received an abnormal chest x-ray, and were ultimately diagnosed with metastatic cancer, had 
a craniotomy procedure done (Table 5). However, an equal number of patients receiving an 
abnormal chest x-ray result, and were ultimately diagnosed with a primary brain tumor, received a 
craniotomy (Table 5). 
The number of brain lesions a patient has showed about the same selectivity that a chest x-
ray did in separating patients with a primary brain tumor from those with metastatic cancer (Table 
6). If the number of brain lesions a patient had was used as the final diagnostic test, then six 
people out of 48 would have been misdiagnosed (12.5%). Table 7 combines the criteria of 
number of brain lesions versus chest x-ray results. This indicates that in this study that 90.9% of 
patients with a single brain lesion and a normal chest x-ray had a primary brain tumor, and that 
83.3% of patients with two brain lesions and an abnormal chest x-ray had a metastatic brain 
tumor. There were eight patients which had indicators for both primary and metastatic brain 
lesions. For patients which had a single brain lesion and an abnormal chest x-ray, 83.3% of them 
had a primary brain tumor. From this it appears that a single brain lesions was a better indicator 
for a primary brain tumor. These criteria still do not show the accuracy rate observed in the 
selection ofbiopsy sites for the patients. 
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One possibility for why this is the case may be that an MRI or CT scan is sensitive enough 
to distinguish between primary brain tumors and metastatic brain tumors and other potential brain 
lesions, so less people are receiving ancillary testing. There appears to be some evidence from the 
patient files. If a head scan alone is sensitive enough to distinguish a primary lesion from a 
metastatic lesion, then the admitting physician can be more selective of patients who receive more 
advanced ancillary testing. In general though, it appears that most patients receive a chest x-ray 
as a standard diagnostic test, and that this may affect the choice of a biopsy site. 
To further compare the value of a chest x-ray and chest CT as ancillary tests, a greater 
population of patients who have had both scans needs to be obtained. These data need to be 
interpreted cautiously, as the data is not completely collected yet, and it is possible that the 
current trends in the data could change. Further plans for the study include finishing data 
collection as well as retrospective evaluation of the initial head scans for each patient. The initial 
MRI and CT head scans for each patient have been collected, to allow various diagnosing 
physicians to predict the final diagnosis based upon the head scan alone, without knowing the 
actual diagnosis of the patient. This could provide a better understanding of the factors that 
influence the patient's diagnostic procedure, and what factors allow the accurate preliminary 
diagnosis of a suspected brain tumor. 
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Table 1. Prevalence of Ancillary Scanning 
Patients 
Ancillary Test 
Number Percentage a 
Chest X-Ray 47 97.9 
Chest CT 9 18.8 
Abdominal CT 5 10.4 
Bone Scan 0 0 
aTotal number ofpatients=48. 
Table 2. Distribution of Ancillary Scanning and Diagnosis Among 
Patients Receiving a Chest X-Ray. 
Chest Abdominal Final 
X-ra'; 
Chest CT 
CT 
Diagnostic Test 
Diagnosis
Normal" 35 Normal 2 Normal 1 Brain Biopsy 16 Primary 31 
Abnormal 0 Abnormal 3 Brain Resectionc 19 Metastatic 4 
Not Done 33 Not Done 31 Non-brain Biopsy 0 
Abnormalb 12 Normal 0 Normal I Brain Biopsy 3 Primary 6 
Abnormal 7 Abnormal 0 Brain Resection 2 Metastatic 6 
Not Done 5 Not Done 11 Non-brain Biopsy 5 
Not Done 2 
Normal radiological examinations showed no indications of nodules, lesions or other 
irregularities or air-space disease. 
b Abnormal radiological examinations revealed possible cancerous nodules, lesions or air-
space disease. 
cA complete removal of tumor tissue. 
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Table 3. Comparison of Final Diagnosis to Results of Chest X-Ray and Chest CT 
Chest X-Ray ChestCT 
Final Diagnosis 
Normal Abnormalb Normal Abnormal 
Primary Brain Twnor 3 2 l 2 l 
Metastatic Brain Twnor 6 0 6 0 6 
a-bsee Table 2. 
Table 4. History of Patients with Metastatic Cancer Who Had a Normal Chest X-ray 
Patient 
Number of 
Chest CT Abdominal CT Diagnostic Test 
Lesions8 
1 1 Not Done Not Done Brain Resectionb 
2 I Not Done Not Done Brain Resection 
3 2 Not Done Not Done Brain Resection 
4 1 Not Done Not Done Brain Biopsy 
8The number of brain lesions observed from the patients first CT or MRI brain scan. 
bSee Table 2. 
Table 5. Distribution of Diagnostic Tests Among Patients Receiving 
Abnormal Chest X-Rays 
Final Diagnosis 
Diagnostic Procedure 
Primary Metastatic 
Brain Biopsy 3 0 
Brain Resectiona 2 0 
Non-brain Biopsy 0 5 
Not Done 1 1 
See Table 2. 
13 
) 
CHEST CT USAGE FOR BRAIN TUMOR EVALUATION 
Table 6. Comparison of the Distribution of Chest Scans and Resulting Diagnosis 
of Patients with One and Two Brain Lesions. 
Number of 
Lesions• 
One 40 
Two 8 
asee Table 4. 
b-dSee Table 2. 
Chest X-Ray 
Normalb 33 
Abnormalc 6 
Not Done 1 
Normal 2 
Abnormal 6 
Not Done 0 
ChestCT 
Normal 2 
Abnormal 2 
Not Done 36 
Normal 0 
Abnormal 5 
Not Done 3 
Diagnostic Test Final Diagnosis 
Brain Biopsy 17 Primary 36 
Brain Resectiond 21 
Non-brain Biopsy 1 Metastatic 4 
Not Done 1 
Brain Biopsy 2 Primary 2 
Brain Resection 1 
Non-brain Biopsy 4 Metastatic 6 
Not Done 1 
Table 7. Comparison of Lesion Number and Chest X-Ray Results with Final Diagnosis 
Number of Lesions 
One 
Two 
asee Table 4. 
See Table 2. 
39 
8 
Chest X-Ray 
Normalb 33 
Abnormalc 6 
Normal 2 
Abnormal 6 
1 4 
Final Diagnosis 
Primary 30 
Metastatic 3 
Primary 5 
Metastatic 1 
Primary 1 
Metastatic 1 
Primary 1 
Metastatic 5 
) 
CHEST CT USAGE FOR BRAIN TUMOR EVALUATION 
REFERENCES 
Black, P and Wen, PY. 1995. "Clinical, imaging and laboratory diagnosis ofbrain tumors." 
In Brain Tumors: An Encyclopedic Approach. Ed. AH Kaye and ER Laws Jr. Churchill, 
Livingstone: New York, 191-214. 
Das, A and Hochberg, FH. 1996. Clinical Presentation oflntracranial Metastases. Neurosurgery 
Clinics of North America. 7(3): 377-391. 
Henson, JW. 1999. "Glioblastoma Multiforme and Anaplastic Astrocytoma, Anaplastic 
Oligodendroglioma: A Guide For Patients." MGH Brain Tumor Center. 
Posner, JB. 1995. "Neurologic Complications of Cancer." Contemporary Neurology Series, vol. 
45. Davis, Philadelphia, 3-14. 
Scaefer, PW, Budzik, RF, and RG Gonzalez. 1996. Imaging of Cerebral Metastases. 
Neurosurgery Clinics of North America. 7(3): 393-423. 
Silverstein, MD, Cascino, TL, and WS Harmsen. 1996. High-Grade Astrocytomas: Resource use, 
Clinical Outcomes, and Cost of Care. Mayo Clinic Proceedings. 71(10): 936-944. 
Walker, AE, Robins M, and FD Weinfeld. 1985. Epidemiology ofbrain tumors: The national 
survey of intracranial neoplasms. Neurology. 35(2): 219-226. 
15 
SOUTHERN SCHOLARS SENIOR PROJECT 
Name: 
Major: 
Senior Project 
A significant scholarly project, involving research, writing, or special performance, 
appropriate to the major in question, is ordinarily completed the senior year. Ideally, 
this project will demonstrate an understanding of the relationship between the student's 
major field and some other discipline. The project is expected to be of sufficiently high 
quality to warrant a grade of A and to justify public presentation. The completed 
project. to be turned in in duplicate. must be approved by the Honors Committee in 
consultation with the student's supervising professor three weeks prior to graduation. 
The 2-3 hours of credit for this project is done as directed study or in a research class. 
Approval to be signed by faculty advisor when project is completed: 
This project has been completed as planned: 
The project is worth 2-3 hours of credit: 
r 
Advisor's Final Signature 
Chair, Honors Committee __________ Date Approved: ___ _ 
! 
